Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases. Consolidated revenue for 2015 was € 1,047.7 million, operating income was € 278.5 million and net income was € 198.8 million.
Recordati has 1.23k Twitter Followers. The number of followers has increased 0.4% month over month and increased 1.1% quarter over quarter
When was Recordati founded?
Recordati was founded in 1926.
Who are Recordati key executives?
Recordati's key executives are Fritz Squindo, Enrico Baroncia and Gabriele Finzi.
How many employees does Recordati have?
Recordati has 1,998 employees.
Who are Recordati competitors?
Competitors of Recordati include BERLIN-CHEMIE, BiosPacific and Douglas Pharmaceuticals.
Where is Recordati headquarters?
Recordati headquarters is located at Via Matteo Civitali, 1, Milano.
Where are Recordati offices?
Recordati has an office in Milano.
How many offices does Recordati have?
Recordati has 1 office.
Receive alerts for 300+ data fields across thousands of companies